Form 4 Tracker
Harmony Biosciences Holdings, Inc.
HRMY

20 insider filings · Latest: Sep 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 21, 2025Jan 21 9:21 PMJEFFREY M DAYNO
Proposed Sale
19,293$39.05$753.4K—

View →

Jan 21, 2025Jan 21 9:20 PMJEFFREY G DIERKS
Proposed Sale
1,123$39.05$43.9K—

View →

Jan 13, 2025Jan 13 9:26 PMJEFFREY G DIERKS
Proposed Sale
47,162$33.86$1.6M—

View →

Oct 29, 2024Oct 29 8:22 PMJEFFREY G DIERKS
Proposed Sale
21,496$35.75$768.5K—

View →

Oct 3, 2024Oct 3 8:32 PMJEFFREY G DIERKS
Proposed Sale
14,961$35.57$532.2K—

View →

Oct 1, 2024Oct 1 8:35 PMJEFFREY G DIERKS
Proposed Sale
21,796$40.00$871.8K—

View →

Sep 30, 2024Sep 30 8:28 PMJEFFREY G DIERKS
Proposed Sale
7,175$39.13$280.8K—

View →

Sep 27, 2024Sep 27 8:24 PMJEFFREY G DIERKS
Proposed Sale
28,971$39.79$1.2M—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 18, 2026Sep 18 8:48 PMKumar BudurCHIEF MEDICAL OFFICER
Option Exercise
35,852$30.6937,500(D)

View →

Sep 17, 2026Sep 18 8:48 PMKumar BudurCHIEF MEDICAL OFFICER
Option Exercise
800$30.6962,946(D)

View →

Sep 16, 2026Sep 18 8:48 PMKumar BudurCHIEF MEDICAL OFFICER
Option Exercise
1,800$30.6963,346(D)

View →

Sep 8, 2026Sep 9 9:12 PMKumar BudurCHIEF MEDICAL OFFICER
Option Exercise
22,954$30.6964,246(D)

View →

May 14, 2026May 19 1:51 AMGeno J GermanoDirector
Grant/Award
21,231$30.7621,231(D)

View →

May 14, 2026May 18 8:19 PMLinda M SzyperDirector
Grant/Award
21,872$30.7621,872(D)

View →

May 14, 2026May 18 8:18 PMRon M PhilipDirector
Grant/Award
21,872$30.7621,872(D)

View →

May 14, 2026May 18 8:18 PMMark R. GrafDirector
Grant/Award
21,872$30.7621,872(D)

View →

May 14, 2026May 18 8:17 PMJuan A. SabaterDirector
Grant/Award
21,872$30.7621,872(D)

View →

May 14, 2026May 18 8:15 PMGary SenderDirector
Grant/Award
21,872$30.7621,872(D)

View →

May 1, 2026May 18 8:14 PMKumar BudurCHIEF MEDICAL OFFICER
Option Exercise
18,750—37,500(D)

View →

Apr 14, 2026May 18 8:13 PMGlenn ReicinCHIEF FINANCIAL OFFICER
Grant/Award
164,309$29.29164,309(D)

View →

Apr 7, 2026Apr 9 8:15 PMAdam H. ZaeskeCHIEF COMMERCIAL OFFICER
Option Exercise
7,500—7,500(D)

View →

Apr 2, 2026Apr 6 8:16 PMPeter AnastasiouCHIEF OPERATING OFFICER
Grant/Award
212,241$27.74212,241(D)

View →

Apr 2, 2026Apr 6 8:14 PMTroy A. IgnelziDirector
Grant/Award
17,710$27.7417,710(D)

View →

Jan 25, 2026Jan 26 9:49 PMSandip KapadiaCHIEF FINANCIAL OFFICER
Option Exercise
4,725—14,175(D)

View →

Jan 24, 2026Jan 26 9:49 PMSandip KapadiaCHIEF FINANCIAL OFFICER
Option Exercise
3,813—7,625(D)

View →

Jan 22, 2026Jan 26 9:49 PMSandip KapadiaCHIEF FINANCIAL OFFICER
Grant/Award
54,800$36.7612,200(D)

View →

Jan 25, 2026Jan 26 9:48 PMAndrew SerafinCHIEF STRATEGY OFFICER
Option Exercise
2,600—7,800(D)

View →

Jan 24, 2026Jan 26 9:48 PMAndrew SerafinCHIEF STRATEGY OFFICER
Option Exercise
2,500—5,000(D)

View →

Page 1 of 2

Next →